Genmab Announces Multiple Abstracts to be Presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
26/5 23:00
Media Release Copenhagen, Denmark, May 2 6 , 202 2 Multiple epcoritamab (DuoBody ® -CD3xCD20 ) p oster presentations highlighting data in a variety of treatment settings and hematologic malignancies Oral presentation of tisotumab vedotin first-line combination study in patients with recurrent or...